Concord Biotech Ltd Annually Results

Gross Sales

1,016.94

853.17

712.93

616.94

Excise Duty

0

0

0

0

Net Sales

1,016.94

853.17

712.93

616.94

Other Operating Income

0

0

0

0

Other Income

37.15

37.27

23.42

13.81

Total Income

1,054.09

890.44

736.35

630.75

Total Expenditure

585.38

509.88

443.3

289.84

PBIDT

468.71

380.56

293.05

340.91

Interest

2.55

4.51

5.48

0.67

PBDT

466.16

376.05

287.57

340.24

Depreciation

53.59

54.03

50.05

27.52

Minority Interest Before NP

0

0

0

0

Tax

99.83

79.55

58.88

75.49

Deferred Tax

4.63

2.38

3.7

2.34

Reported Profit After Tax

308.1

240.09

174.93

234.89

Minority Interest After NP

0

0

0

0

Net Profit after Minority Interest

308.1

240.09

174.93

234.89

Extra-ordinary Items

0

0

0

0

Adjusted Profit After Extra-ordinary item

308.1

240.09

174.93

234.89

EPS (Unit Curr.)

29.45

22.95

183.34

246.92

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

875

0

0

0

Equity

10.46

10.46

9.51

9.51

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

46.09

44.6

41.1

55.25

PBDTM(%)

45.83

44.07

40.33

55.14

PATM(%)

30.29

28.14

24.53

38.07